Miloslav Kverka

4.3k total citations
64 papers, 2.7k citations indexed

About

Miloslav Kverka is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Miloslav Kverka has authored 64 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 18 papers in Epidemiology and 13 papers in Genetics. Recurrent topics in Miloslav Kverka's work include Gut microbiota and health (28 papers), Clostridium difficile and Clostridium perfringens research (9 papers) and Inflammatory Bowel Disease (8 papers). Miloslav Kverka is often cited by papers focused on Gut microbiota and health (28 papers), Clostridium difficile and Clostridium perfringens research (9 papers) and Inflammatory Bowel Disease (8 papers). Miloslav Kverka collaborates with scholars based in Czechia, United States and Belarus. Miloslav Kverka's co-authors include Helena Tlaskalová‐Hogenová, Tomáš Hudcovic, Zuzana Jirásková Zákostelská, Klára Klimešová, P Roßmann, Martin Kostovčík, Renáta Štëpánková, Jakub Mrázek, Zuzana Stehlíková and Helena Tlaskalová-Hogenová and has published in prestigious journals such as PLoS ONE, Biomaterials and Scientific Reports.

In The Last Decade

Miloslav Kverka

62 papers receiving 2.6k citations

Peers

Miloslav Kverka

EPIDE

GENET

PHYSI

Hannah Fehlner-Peach United States

Bejan Saeedi United States

Xiangsheng Huang United States

Jordi M. Lanis United States

Jianzhong Hu United States

Kirsty Brown Canada

Heidi Schilter Australia

Kristine A. Kuhn United States

Diana Ir United States

Marı́a Julieta González Chile

Hannah Fehlner-Peach United States

Miloslav Kverka

1.4k ×0.9

367 ×0.7

EPIDE

386 ×0.9

362 ×0.9

GENET

491 ×1.2

PHYSI

Citations per year, relative to Miloslav Kverka Miloslav Kverka (= 1×) peers Hannah Fehlner-Peach

Countries citing papers authored by Miloslav Kverka

Since Specialization

Citations

This map shows the geographic impact of Miloslav Kverka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miloslav Kverka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miloslav Kverka more than expected).

Fields of papers citing papers by Miloslav Kverka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miloslav Kverka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miloslav Kverka. The network helps show where Miloslav Kverka may publish in the future.

Co-authorship network of co-authors of Miloslav Kverka

This figure shows the co-authorship network connecting the top 25 collaborators of Miloslav Kverka. A scholar is included among the top collaborators of Miloslav Kverka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miloslav Kverka. Miloslav Kverka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Coufal, Štěpán, Miloslav Kverka, Jakub Kreisinger, et al.. (2023). Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD. Journal of Immunology Research. 2023. 1–16. 3 indexed citations

Rob, Filip, Zuzana Stehlíková, Jakub Kreisinger, et al.. (2022). Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study. PLoS ONE. 17(12). e0277576–e0277576. 4 indexed citations

Kverka, Miloslav, Róbert Hromádka, Klara Kostovcikova, et al.. (2021). Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. Microorganisms. 9(5). 957–957. 128 indexed citations

Roubalová, Radka, Martin Kolář, Zuzana Stehlíková, et al.. (2021). Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy. Cells. 10(11). 3188–3188. 21 indexed citations

Coufal, Štěpán, Martin Kostovčík, M Čermáková, et al.. (2020). Diet Rich in Simple Sugars Promotes Pro-Inflammatory Response via Gut Microbiota Alteration and TLR4 Signaling. Cells. 9(12). 2701–2701. 65 indexed citations

Stehlíková, Zuzana, Vojtěch Tláskal, Radka Roubalová, et al.. (2019). Oral Microbiota Composition and Antimicrobial Antibody Response in Patients with Recurrent Aphthous Stomatitis. Microorganisms. 7(12). 636–636. 44 indexed citations

Zákostelská, Zuzana Jirásková, et al.. (2019). Microbiota, immunity and immunologically-mediated diseases. Vnitřní lékařství. 65(2). 98–107. 4 indexed citations

Stehlíková, Zuzana, Klara Kostovcikova, Miloslav Kverka, et al.. (2019). Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model. Frontiers in Microbiology. 10. 236–236. 48 indexed citations

Kokešová, Alena, Štěpán Coufal, Barbora Frýbová, Miloslav Kverka, & Michal Rygl. (2019). The intestinal fatty acid-binding protein as a marker for intestinal damage in gastroschisis. PLoS ONE. 14(1). e0210797–e0210797. 19 indexed citations

10.

Stehlíková, Zuzana, Martin Kostovčík, Klara Kostovcikova, et al.. (2019). Dysbiosis of Skin Microbiota in Psoriatic Patients: Co-occurrence of Fungal and Bacterial Communities. Frontiers in Microbiology. 10. 438–438. 77 indexed citations

11.

Štěpán, J, et al.. (2019). Update on Menopausal Hormone Therapy for Fracture Prevention. Current Osteoporosis Reports. 17(6). 465–473. 39 indexed citations

12.

Zákostelská, Zuzana Jirásková, Klára Klimešová, P Roßmann, et al.. (2016). Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response. PLoS ONE. 11(7). e0159539–e0159539. 132 indexed citations

13.

Kverka, Miloslav, et al.. (2014). Immunogenicity of coiled-coil based drug-free macromolecular therapeutics. Biomaterials. 35(22). 5886–5896. 24 indexed citations

14.

Tlaskalová-Hogenová, Helena, Luca Vannucci, Klára Klimešová, et al.. (2014). Microbiome and Colorectal Carcinoma. The Cancer Journal. 20(3). 217–224. 49 indexed citations

15.

Hansen, Camilla Hartmann Friis, Dennis Sandris Nielsen, Miloslav Kverka, et al.. (2012). Patterns of Early Gut Colonization Shape Future Immune Responses of the Host. PLoS ONE. 7(3). e34043–e34043. 238 indexed citations

16.

Kverka, Miloslav, et al.. (2012). Sperm Cells Induce Distinct Cytokine Response in Peripheral Mononuclear Cells from Infertile Women with Serum Anti-Sperm Antibodies. PLoS ONE. 7(8). e44172–e44172. 3 indexed citations

17.

Roßmann, P, et al.. (2012). Colostrum of Healthy Mothers Contains Broad Spectrum of Secretory IgA Autoantibodies. Journal of Clinical Immunology. 32(6). 1372–1380. 18 indexed citations

18.

Kverka, Miloslav, et al.. (2007). Antileukotrienic N-arylethyl-2-arylacetamides in the treatment of ulcerative colitis. European Journal of Medicinal Chemistry. 42(8). 1084–1094. 3 indexed citations

19.

Kokešová, Alena, L. Frolová, Miloslav Kverka, et al.. (2006). Oral administration of probiotic bacteria (E. coli nissle,E. coli O83,Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice. Folia Microbiologica. 51(5). 478–484. 51 indexed citations

20.

Tlaskalová‐Hogenová, Helena, Ludmila Tučková, Renáta Štëpánková, et al.. (2005). Involvement of Innate Immunity in the Development of Inflammatory and Autoimmune Diseases. Annals of the New York Academy of Sciences. 1051(1). 787–798. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact